Search

everythinglearnresearchcommunity

for

Search:↓

Most people with alopecia areata have nail changes, which are common but don't greatly affect their quality of life.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

The FDA approved a new Pfizer drug for hair loss in teens.

The main goal for new Alopecia Areata treatments should be significant improvement in scalp hair growth.

Alopecia Areata can affect nails, often improving on its own, but JAK inhibitors may help.

More research is needed on alopecia areata treatments and its psychological effects.

Alopecia areata treatments should be personalized, using options like steroids, JAK inhibitors, and other therapies based on individual needs.

Amphetamines may not directly cause hair loss, as the type of thinning seen with their use differs from severe alopecia.

Baricitinib is effective and safe for treating alopecia areata in Korea.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

Ritlecitinib shows promise in improving hair regrowth in adolescents with alopecia areata.

Ritlecitinib is generally safe for long-term use, with mostly mild side effects.

Oral JAK inhibitors effectively treat alopecia areata and are generally well-tolerated.

Ritlecitinib effectively reduces hair loss in JAK inhibitor-naïve alopecia areata patients.

The guideline recommends personalized treatment for alopecia areata, including new oral medications and psychological support.

Alopecia areata significantly harms women's self-image, causing reduced confidence and social isolation.

An imbalanced scalp microbiome may worsen alopecia areata severity and inflammation, but treatment can partially restore balance.

Alopecia areata in US adolescents leads to significant healthcare costs and usage.

Deuruxolitinib effectively regrows hair in adults with alopecia areata and is well tolerated.

The author clarifies that alopecia areata incognito and diffuse alopecia areata are different types of hair loss with unique symptoms and challenges in diagnosis.

Black dots under trichoscopy can appear in different hair and scalp conditions, not just in alopecia areata.

Ritlecitinib shows promise for treating alopecia areata, especially with early and extended treatment.

Alopecia areata in Romania has a high economic burden, with significant costs and unequal healthcare access.

Dupilumab helped an 11-year-old boy regrow hair and reduce skin rashes.

Alopecia areata treatments include immune inhibitors, topical sensitizers, irritants, and minoxidil, with future focus on immunosuppressive approaches.

A new mouse model helps understand and find treatments for alopecia areata.

Combining light therapy, acid, and microneedling improves hair regrowth in stubborn hair loss cases.

Dupilumab for skin problems might reactivate hair loss in some patients.

Alopecia areata is a chronic condition causing hair loss, with new treatments targeting the immune system showing promise.

Many patients with Alopecia Areata in Korea experience anxiety, depression, and reduced quality of life, which are often unrelated to the severity of hair loss.